Invesco Ltd. Keros Therapeutics, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 33,266 shares of KROS stock, worth $448,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,266

Previous 12,616 163.68%

Holding current value

$448,758

Previous $199,000 69.85%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$10.15 - $16.1 $209,597 - $332,465	20,650 Added 163.68%	33,266 $338,000
Q4 2024 Feb 13, 2025	BUY	$15.64 - $70.0 $7,084 - $31,710	453 Added 3.72%	12,616 $199,000
Q3 2024 Nov 12, 2024	BUY	$41.68 - $58.07 $12,420 - $17,304	298 Added 2.51%	12,163 $706,000
Q2 2024 Aug 13, 2024	SELL	$44.58 - $66.89 $3.42 Million - $5.14 Million	-76,818 Reduced 86.62%	11,865 $542,000
Q1 2024 May 14, 2024	BUY	$41.26 - $70.48 $3.25 Million - $5.55 Million	78,703 Added 788.61%	88,683 $5.87 Million
Q4 2023 Feb 12, 2024	SELL	$27.12 - $41.05 $178,205 - $269,739	-6,571 Reduced 39.7%	9,980 $396,000
Q3 2023 Nov 13, 2023	BUY	$31.57 - $43.02 $170,762 - $232,695	5,409 Added 48.55%	16,551 $527,000
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $26,082 - $35,707	700 Added 6.7%	11,142 $447,000
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $108,365 - $155,121	2,615 Added 33.41%	10,442 $445,000
Q4 2022 Feb 13, 2023	SELL	$39.45 - $51.77 $9,034 - $11,855	-229 Reduced 2.84%	7,827 $375,000
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $223,956 - $323,206	8,056 New	8,056 $303,000
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $181,689 - $467,939	-6,980 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $1,811 - $2,552	43 Added 0.62%	6,980 $379,000
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $25,495 - $43,394	-690 Reduced 9.05%	6,937 $406,000
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $1.99 Million - $2.97 Million	-67,877 Reduced 89.9%	7,627 $301,000
Q2 2021 Aug 17, 2021	SELL	$42.4 - $70.11 $4.91 Million - $8.13 Million	-115,919 Reduced 60.56%	75,504 $3.21 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $92,016 - $128,277	1,704 Added 0.9%	191,423 $11.8 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $58,932 - $135,445	1,637 Added 0.87%	189,719 $13.4 Million
Q3 2020 Nov 16, 2020	SELL	$27.04 - $62.21 $3.08 Million - $7.08 Million	-113,743 Reduced 37.69%	188,082 $7.25 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $6.06 Million - $12.2 Million	301,825 New	301,825 $11.3 Million

Others Institutions Holding KROS

# of Institutions

178

Shares Held

36.4M

Call Options Held

938K

Put Options Held

1.39M

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $347M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account